Fig. 2: Kaplan–Meier survival curves by treatment regimens. | Blood Cancer Journal

Fig. 2: Kaplan–Meier survival curves by treatment regimens.

From: Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Fig. 2

This figure illustrates Kaplan–Meier curves of treatment-naïve mutated TP53 AML patients, stratified by the treatment received—HMA + VEN vs. HMA: A Median Duration of Response. B Event-Free Survival. C Overall Survival.

Back to article page